TP53 and colorectal carcinoma: Over 10–15 years, the progressive accumulation of genetic and epigenetic alterations—such as mutations in APC, KRAS, and TP53—drives the transformation of this polyp into an invasive CRC (Xu et al., 2023; Tong et al., 2022).